The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis

Authors
Category Primary study
Year 2005
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Epistemonikos ID: 8b54bacb49d237be71c7fd5d1a6b29b9bfbcbd2d
First added on: Apr 19, 2023